Embecta (FRA:JX7) Net Issuance of Preferred Stock : €0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Embecta's net issuance of preferred for the three months ended in Mar. 2024 was €0 Mil. The number is 0, which means that Embecta has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Embecta's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2024 was €0 Mil.

Embecta Net Issuance of Preferred Stock Historical Data

The historical data trend for Embecta's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Net Issuance of Preferred Stock Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Net Issuance of Preferred Stock

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial											-	-	-	-	-

Embecta Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Embecta Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Embecta's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines